Markets:

Overview

News

Currencies

International

Treasuries

Fortress Biotech, Inc. - Common Stock (NQ:FBIO)

2.830 +0.080 (+2.91%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 5, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Fortress Biotech, Inc. - Common Stock

< Previous 1 2 3 4 Next >

Why Smith Micro Software Shares Are Trading Lower By Over 46%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

February 27, 2023

Gainers Lucira Health, Inc. (NASDAQ: LHDX) jumped 354% to $0.6369 after the company announced FDA authorization for its at-home combination COVID-19 & flu test.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

February 27, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

February 14, 2023

Via Benzinga

Fortress Biotech: Q2 Earnings Insights ↗

August 11, 2022

Fortress Biotech (NASDAQ:FBIO) reported its Q2 earnings results on Thursday, August 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

Recap: Fortress Biotech Q4 Earnings ↗

March 28, 2022

Fortress Biotech (NASDAQ:FBIO) reported its Q4 earnings results on Monday, March 28, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

January 17, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

December 21, 2022

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

December 14, 2022

Via Benzinga

Fortress Bio’s Portfolio Of Marketed Drugs Could Soon See Three Additions

October 06, 2022

By Rachael Green, Benzinga

Via News Direct

Fortress Bio’s Portfolio Of Marketed Drugs Could Soon See Three Additions

October 06, 2022

Fortress Biotech Inc. (NASDAQ: FBIO) is a biopharmaceutical company focused on developing a range of high-potential treatments on its own and through its growing portfolio of subsidiaries and partner...

Via TheNewswire.com

Stocks That Hit 52-Week Lows On Friday ↗

December 23, 2022

OnFriday, 143 stocks hit new 52-week lows.

Via Benzinga

Fortress Bio's Portfolio Of Marketed Drugs Could Soon See Three Additions ↗

October 05, 2022

Via Benzinga

Fortress Biotech Earnings Perspective: Return On Capital Employed ↗

September 08, 2022

Benzinga Pro data, Fortress Biotech (NASDAQ:FBIO) reported Q2 sales of $18.89 million. Earnings fell to a loss of $53.93 million, resulting in a 9.0% decrease from last quarter.

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

August 12, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2022 ↗

August 04, 2022

Upgrades

Via Benzinga

B. Riley Securities Maintains Buy Rating for Fortress Biotech: Here's What You Need To Know ↗

July 14, 2022

B. Riley Securities has decided to maintain its Buy rating of Fortress Biotech (NASDAQ:FBIO) and lower its price target from $8.00 to $6.00. Shares of Fortress Biotech are trading down 1.01% over the...

Via Benzinga

36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022

May 16, 2022

RALEIGH, NC / ACCESSWIRE / May 16, 2022 / The Spring into Action- Best Ideas Virtual Investor Conference will take place on May 16th - 20th, 2022, where 36 SmallCap, MicroCap and NanoCap public...

From MicroCap Rodeo

Via AccessWire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

April 06, 2022

Gainers

Via Benzinga

Looking Into Fortress Biotech's Return On Capital Employed ↗

March 29, 2022

Benzinga Pro data, Fortress Biotech (NASDAQ:FBIO) reported Q4 sales of $18.28 million. Earnings fell to a loss of $68.51 million, resulting in a 49.38% decrease from last quarter.

Via Benzinga

Fortress Biotech, Inc. (NASDAQ: FBIO) Featured in Virtual Coverage of the 34th Annual Roth Conference

March 16, 2022

Via Investor Brand Network

Stocks That Hit 52-Week Lows On Wednesday ↗

March 02, 2022

Wednesday's session saw 107 companies set new 52-week lows. Points of Interest From Today's 52-Week Lows: Citigroup (NYSE:C) was the largest company by...

Via Benzinga

Benzinga Announces This Week's All Access Guests ↗

February 10, 2022

Benzinga is thrilled to announce the guest lineup for our next All Access show, sponsored by TiiCKER, set to air Friday, February 11 at 9:15 am ET. The Lineup 9:15 am...

Via Benzinga

36 of the Best Ideas Companies to Present at the 2nd Annual Winter Wonderland Virtual Investor Conference on February 8th - 11th, 2022

January 28, 2022

RALEIGH, NC / ACCESSWIRE / January 28, 2022 / The Winter Wonderland Best Ideas Virtual Investor Conference will take place on February 8th - 11th, 2022, where 36 SmallCap, MicroCap and NanoCap public...

From MicroCap Rodeo

Via AccessWire

FDA Holds Mustang Bio's Gene Therapy IND For Compromised Immune System Disorder ↗

January 25, 2022

The FDA has issued a hold, pending Chemistry, Manufacturing & Controls (CMC) clearance, on Mustang Bio Inc's (NASDAQ: MBIO) Investigational New Drug (IND)...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

December 15, 2021

Gainers Calliditas Therapeutics (NASDAQ:

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

November 15, 2021

Gainers Kezar Life Sciences (NASDAQ:KZR) s...

Via Benzinga

Aegis Capital Corp. acted as Sole Bookrunner on a $2.6 Million Public Offering of Common Stock for Avenue Therapeutics (NASDAQ: ATXI)

November 12, 2021

NEW YORK, NY / ACCESSWIRE / November 12, 2021 / Aegis Capital Corp. acted as Sole Bookrunner on a $2.6 Million Public Offering of Common Stock for Avenue Therapeutics (NASDAQ:ATXI). About Avenue...

From Aegis Capital Corp.

Via AccessWire

Topics Retirement

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 14, 2021

Gainers NRX Pharmaceuticals (NASDAQ:NRXP) stock increased by 34.63% to $12.71 during Thursday's pre-market session. The company's market cap stands at $683.4...

Via Benzinga

18 Stocks Moving in Thursday's Pre-Market Session ↗

October 14, 2021

Gainers TSR, Inc. (NASDAQ: TSRI) rose 40.2% to $12.89 in pre-market trading after the company reported record revenue for its first quarter. Cemtrex, Inc. (NASDAQ: CETX) rose 34....

Via Benzinga

The Daily Biotech Pulse: Moderna Awaits Adcom Ruling On COVID-19 Booster Shot; Teligent Files For Chapter 11; CFO Transitions at Catalyst Biosciences, CRISPR; Lucid Diagnostics Debuts ↗

October 14, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Catalyst Biosciences Announces Resignation Of CFO Catalyst Biosciences, Inc...

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.